Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
01/2000
01/11/2000US6012375 Aircraft infrared guided defense missile system
01/10/2000CA2277406A1 Production of protein preparations with a reduced aggregate content
01/06/2000WO2000000825A2 Detection and modulation of cellular immunity to immune privileged antigens
01/06/2000WO2000000628A1 Replication-defective recombinant adenovirus with mutated major late promoter
01/06/2000WO2000000597A2 Non-symbiotic plant hemoglobins to maintain cell energy status
01/06/2000WO2000000588A2 Porcine spinal cord cells and their use in spinal cord repair
01/06/2000WO2000000587A1 Methods of expanding and selecting disease associated t-cells
01/06/2000WO2000000216A2 Use of poxviruses as enhancer of specific immunity
01/06/2000WO2000000209A2 Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions
01/06/2000WO2000000208A1 Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions
01/06/2000WO2000000186A1 Method of treating topical ailments
01/06/2000WO1999058133A3 Anti-diarrheal and method for using the same
01/06/2000CA2336382A1 Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens
01/06/2000CA2335601A1 Porcine spinal cord cells and their use in spinal cord repair
01/06/2000CA2335516A1 Methods of expanding and selecting disease associated t-cells
01/06/2000CA2335508A1 Use of poxviruses as enhancer of specific immunity
01/06/2000CA2332181A1 Replication-defective recombinant adenovirus with mutated major late promoter
01/05/2000EP0968295A1 Vectors having enhanced expression and methods of making and uses thereof
01/05/2000EP0968284A2 An improved method for the production and purification of adenoviral vectors
01/05/2000EP0968281A2 An oncolytic/immunogenic complementary-adenoviral vector system
01/05/2000EP0967991A1 Infectious bursitis vaccine
01/05/2000EP0967987A1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
01/05/2000EP0967986A2 USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
01/05/2000EP0967928A1 Method and apparatus for altering the osmotic pressure of cryopreserved white stem cells
01/05/2000EP0967878A1 Targeted cytotoxic cells
01/05/2000EP0967862A1 Methods and compositions for producing dried, storage-stable platelets
01/05/2000EP0721469B1 Anti-gp39 antibodies and uses therefor
01/05/2000EP0689381B1 Mucosal competitive exclusion flora
01/05/2000EP0610445B1 Use of compositions comprising a bactericidal/permeability increasing protein and a lipid carrier
01/05/2000CN1240146A Medicine for treating skin ringworm and dermatitis and preparation process
01/05/2000CN1240142A Compound longshou soluble granules
01/05/2000CN1240141A Medicinal granule with anti-senility function
01/05/2000CN1240140A Traditional Chinese medicine for treating gastric disease and preparation process thereof
01/05/2000CN1240138A Method for preparing defatting health care wine
01/05/2000CN1047949C Niuhunnggongjing powder medicine and preparation process
01/05/2000CN1047948C Oral natural drug composition for curing hysteromyoma
01/05/2000CN1047946C Prepration for treating senile diseases
01/05/2000CN1047945C Medicine for treating burn and preparation process thereof
01/05/2000CN1047940C Medicine for curing gastric and duodenal ulcer
01/05/2000CN1047939C Compound Chinese herbal set prescription medicine for treating male infertility
01/05/2000CN1047938C Traditional Chinese medicine for treating headache
01/05/2000CN1047937C Process for preparing instant tortoise-plastron glue granule or powder preparation to be taken ofter being infused in boiling water
01/05/2000CN1047925C Method for making edible health-care insect products
01/05/2000CN1047923C Bone emulsion products and preparation process thereof
01/04/2000US6010894 Using brain membrane receptor; forming vaccines
01/04/2000US6010890 Method for viral inactivation and compositions for use in same
01/04/2000US6010883 Recombinant fusion proteins
01/04/2000US6010874 Early onset alzheimer's disease gene and gene products
01/04/2000US6010721 Glycyrrhetinic-acid-like factor
01/04/2000US6010697 Cancer aftertreament
01/04/2000US6010696 Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
01/04/2000US6010694 Fibrillin 1 gene comprising duplication mutation and compositions and kits using the same
01/04/2000US6010633 Method of preventing air from becoming entrapped within a filtration device
01/04/2000US6010627 Device for concentrating plasma
01/04/2000CA2194103C Polypeptides useful as calcium channel blockers
12/1999
12/29/1999WO1999067408A1 Mumbaistatin, a process for its production and its use as a pharmaceutical
12/29/1999WO1999067363A1 Ependymal neural stem cells and method for their isolation
12/29/1999WO1999066962A1 Method of inactivating viruses
12/29/1999WO1999066923A1 Application for utility patent for improved enriched platelet wound healant
12/29/1999WO1999066797A1 Enriched platelet wound healant
12/29/1999WO1999042564A3 Apoptotic cell-mediated antigen presentation to dendritic cells
12/29/1999EP0967276A2 Anti-tumor agent comprising salmosin
12/29/1999EP0967273A1 Cell supporting matrix, cell culture device, and fluid treating device
12/29/1999EP0966969A1 Anti-stress drugs and functional foods having anti-stress effects
12/29/1999EP0966534A1 Compositions and methods for elimination of unwanted cells
12/29/1999EP0966523A1 Method for the production of selected lymphocytes
12/29/1999EP0966293A1 Medicine for promoting cicatrization and containing thrombocytes
12/29/1999EP0966292A1 Mononuclear phagocytes and their use to promote axonal regeneration
12/29/1999EP0817680B1 Centrifuged system for intermittent collection of mononuclear cells
12/29/1999EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy
12/29/1999EP0668781B1 Lymphokine gene therapy of cancer in combination with tumor antigens
12/29/1999EP0587711B1 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
12/29/1999EP0564645B1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses
12/29/1999CN1239997A Methods of preserving prokaryotic cells and compositions obtained thereby
12/29/1999CN1239675A Anti-tumor agent comprising salmosin as active ingredient
12/29/1999CN1239672A Externally used medicine for treating frostbite and its preparation
12/29/1999CN1239671A Medicine for treating trachitis and asthma and its preparation
12/29/1999CN1239660A Slow-released analgesic suppository and its preparation process
12/29/1999CN1047721C Bee-glue candy
12/29/1999CA2336217A1 Method of inactivating viruses
12/29/1999CA2336135A1 Mumbaistatin, a process for its production and its use as a pharmaceutical
12/29/1999CA2330175A1 Ependymal neural stem cells and method for their isolation
12/28/1999US6008326 A monospecific antigen protein of haemophililus influenzae; therapy for ear infections, meningitis, pneumonia, and oral diseases
12/28/1999US6008248 An isotonic mixtures comprising medium-chain triglycerides, vegetable oils and fish oil for treating inflammatory reaction, or an increased risk of vascular thrombosis, or severe cardiac arrythmia
12/28/1999US6008197 Activating the freeze dried denatured cells with a denaturing agent solution; use as promoting bone healing or bone formation in mammal
12/28/1999US6008047 Cell culturing method and medium
12/28/1999US6008035 System for the in vivo delivery and expression of heterologous genes in the bone marrow
12/28/1999US6008027 Lactase enzyme replacement capsule containing lactobacillus acidophillus mixed with stabilizing desiccants, then placed in a gelatin capsule, banded and vacuum dried; having lactase activity for 10 hours after ingestion; lactose intolerance
12/28/1999US6007979 Method for reduction of the infectiousness of potentially infectious material
12/28/1999US6007978 Method of freezing cells and cell-like materials
12/28/1999US6007833 Crosslinkable macromers bearing initiator groups
12/28/1999US6007821 Immunosuppression; organ transplants, insulin dependent diabetes
12/28/1999US6007818 Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent
12/28/1999US6007813 Method and composition for treating ulcers and secretion of gastric acid
12/28/1999US6007812 Compound MK7634, process for production thereof, and anthelmintic containing said substance
12/28/1999US6007808 Nutrient mixture of eubiotic bacteria and glutamine or glutamine-containing polypeptide
12/28/1999US6007807 Hybrid fusion cell comprising idiotypic antibody-expressing malignant b cell fused to b cell hybridoma expressing an antibody which is internalized on an antigen presenting cell
12/28/1999US6007774 Administering a biocompatible non-blood oxygen carrier while monitoring one or more oxygenation indices to maintain oxygenation of the patient's tissues at or above a predetermined level
12/28/1999US6006752 Mixed chimerism and tolerance
12/28/1999CA2155169C Process and compositions for activating the differentiation of preadipocyte cells and related therapeutic treatments